Incyte (INCY) Long-Term Investments (2014 - 2026)
Incyte (INCY) reported Long-Term Investments of $54.6 million for Q1 2026, up 212.56% on a YoY basis from $17.5 million in Q1 2025, and up 13.73% quarter-over-quarter from $48.0 million in Q4 2025.
Incyte (INCY) Long-Term Investments (2014 - 2026) Analysis & Trends
Incyte has reported Long-Term Investments for 13 years, with the latest figure at $54.6 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Investments rose 212.56% year-over-year to $54.6 million; the trailing twelve-month figure through Mar 2026 stood at $54.6 million (up 212.56% YoY), and the FY2025 full-year result was $48.0 million, up 155.08% from the prior year.
- Long-Term Investments for Q1 2026 stood at $54.6 million, up from $48.0 million in the prior quarter.
- The five-year high for Long-Term Investments was $287.7 million in Q1 2024, with the low at $1.6 million in Q3 2022.
- Historically, Long-Term Investments has averaged $85.0 million across 5 years, with a median of $48.0 million in 2025.
- Annual changes were most pronounced in 2022 — Long-Term Investments tumbled 99.17% — and 2023, when it jumped 9497.94%.
- Incyte's Long-Term Investments stood at $133.7 million in 2022, then surged by 40.43% to $187.7 million in 2023, then slumped by 89.98% to $18.8 million in 2024, then surged by 155.08% to $48.0 million in 2025, then rose by 13.73% to $54.6 million in 2026.
- The last three Long-Term Investments figures came in at $54.6 million (Q1 2026), $48.0 million (Q4 2025), and $21.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 54.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.58 Mn |
| Dec 31, 2025 | 47.99 Mn |
| Sep 30, 2025 | 21.87 Mn |
| Jun 30, 2025 | 13.31 Mn |
| Mar 31, 2025 | 17.46 Mn |
| Dec 31, 2024 | 18.81 Mn |
| Sep 30, 2024 | 27.57 Mn |
| Jun 30, 2024 | 29.67 Mn |
| Mar 31, 2024 | 287.66 Mn |
| Dec 31, 2023 | 187.72 Mn |
| Sep 30, 2023 | 153.66 Mn |
| Jun 30, 2023 | 170.32 Mn |
| Mar 31, 2023 | 128.31 Mn |
| Dec 31, 2022 | 133.68 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 149.78 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 221.27 Mn |
| Sep 30, 2021 | 192.10 Mn |
| Jun 30, 2021 | 220.69 Mn |